EUVIMEDEUVIMED entdecken
Crossref

Hemostatic and thrombotic outcomes in patients undergoing therapeutic plasma exchange

Sirui Ma iD, Rushad Patell, Laura Dodge, Shengling Ma, Michelle Knox, Brian J Carney

Transfusion · 2025

DOI: 10.1111/trf.18320 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, 2025. Verfasst von Sirui Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Plasma Exchange, Thrombosis, Hemorrhage, Hemostasis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Whether therapeutic plasma exchange (TPE) results in clinically relevant bleeding or thrombotic events is not well characterized. Study Design and Methods We conducted a single‐institution retrospective cohort study to estimate the incidence of bleeding and thrombotic outcomes of patients treated with TPE from 2017 to 2021. Patients with ≥3 treatment sessions within a 14‐day period were included. Two independent physician reviewers manually reviewed patient charts. We calculated the 30‐day cumulative incidence of bleeding and thrombotic outcomes with 95% confidence intervals (CI). We used a regression model to determine the association between clinical and laboratory features and study outcomes.

Results

The study comprised 145 patients who underwent 176 treatment courses, representing a cumulative total of 890 individual TPE procedures. The cumulative incidence of clinically relevant bleeding (including major bleeding and clinically relevant nonmajor bleeding) was 8.0% (95% CI 4.4%–13.0%), and thrombosis was 4.0% (95% CI 1.6%–8.0%). There was one fatal bleeding event. Older age and chronic kidney disease were associated with odds ratios of 1.08 (95% CI 1.03–1.13, p = .002) and 4.68 (95% CI 1.33–14.90, p = .01), respectively, for bleeding. Patients who received any quantity of fresh frozen plasma as replacement fluid had a bleeding rate of 16.4% compared to 6.6% in patients who did not receive plasma ( p = .05).

Discussion

TPE‐associated bleeding complications occur at a higher rate than previously understood. Further prospective investigations are merited to characterize bleeding risk factors and optimal preventive strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasma ExchangeThrombosisHemorrhageHemostasisHumansFemaleMaleRetrospective StudiesMiddle AgedAgedAdultIncidenceTreatment Outcome

Stichwörter der Autor:innen

hemorrhageplasma exchangeplasmapheresisthrombosistransfusion

Autor:innen und Institutionen

  • Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Division of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Section of Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA.
  • Apheresis Services, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

ORCID-Profile: Sirui Ma

Zitieren

APA

Ma, S., Patell, R., Dodge, L., Ma, S., Knox, M., & Carney, B. J. (2025). Hemostatic and thrombotic outcomes in patients undergoing therapeutic plasma exchange. Transfusion. https://doi.org/10.1111/trf.18320

Vancouver

Ma S, Patell R, Dodge L, Ma S, Knox M, Carney BJ. Hemostatic and thrombotic outcomes in patients undergoing therapeutic plasma exchange. Transfusion. 2025. doi:10.1111/trf.18320

BibTeX
@article{Ma2025,
  author = {Ma, Sirui and Patell, Rushad and Dodge, Laura and Ma, Shengling and Knox, Michelle and Carney, Brian J},
  title = {Hemostatic and thrombotic outcomes in patients undergoing therapeutic plasma exchange},
  journal = {Transfusion},
  year = {2025},
  doi = {10.1111/trf.18320}
}
Kostenlos starten →